Product/Composition:- | Dolutegravir |
---|---|
Strength:- | 10 mg, 25 mg, 50 mg |
Form:- | Tablet |
Reference Brands:- | Tivicay(Us & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Dolutegravir is an HIV-1 treatment from the integrase inhibitor class that blocks viral replication. Approved by the US FDA and EMA, it is used alone or in combination therapies like Tivicay, Triumeq, and Dovato. Known for strong efficacy and once-daily dosing.
Dolutegravir is a potent antiretroviral drug used for the treatment of HIV-1 infection. As an integrase strand transfer inhibitor (INSTI), it blocks the enzyme HIV integrase, preventing viral replication. Dolutegravir is available as a standalone medication (brand name Tivicay) and in fixed-dose combinations like Triumeq, Dovato, and Juluca. Approved by the US FDA and EMA, it is used in both adults and children. Known for its once-daily dosing, high genetic barrier to resistance, and strong efficacy, Dolutegravir is a preferred first-line HIV therapy recommended by WHO and leading HIV treatment guidelines globally. Ideal for long-term HIV management.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications